Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-034038

Chief Financial Officer acquired 35,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Myszkowski Kenneth Allen Chief Financial Officer 2019-05-31 Option exercise +15,000 $4.60 $69,000 293,536 D: show line 1 in the form
Myszkowski Kenneth Allen Chief Financial Officer 2019-05-31 Option exercise +20,000 $5.19 $103,800 313,536 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Myszkowski Kenneth Allen Chief Financial Officer 2019-05-31 Option exercise · Stock Option (right to buy) −15,000 220,000 D: show line 3 in the form
Myszkowski Kenneth Allen Chief Financial Officer 2019-05-31 Option exercise · Stock Option (right to buy) −20,000 200,000 D: show line 4 in the form
Loading xslF345X03/doc4.xml…